Heart stent trial aims to cut bleeding risk with shorter blood thinner course
Disease control
Not yet recruiting
This study compares a new ultrathin drug-coated stent plus a shorter course of dual blood thinners (1-3 months) followed by a single blood thinner, versus the standard 12-month dual blood thinner regimen, in 828 people with left main coronary artery disease. The goal is to see if…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated May 01, 2026 15:59 UTC